Jari Ruokolainen

Jari Ruokolainen

Auto-generated profile, based on publicly available information

Jari Ruokolainen

Faculty of Management and Business Tampere University Tampere Finland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in JMIR Research Protocols
Verified
Journal Article
Open access
MJMilla Jauhiainen
Milla Jauhiainen
JPJuha Puustinen
Juha Puustinen
SMSaeed Mehrang
Saeed Mehrang
JRJari Ruokolainen
Jari Ruokolainen
AHAnu Holm
Anu Holm
HNHannu Nieminen
Hannu Nieminen
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Clinical motion characterization in patients with Parkinson’s disease (PD) is challenging: symptom progression, suitability of medication, and level of independence in the home environment can vary across time and from patient to patient. Appointments at the neurological outpatient clinic provide a limited understanding of the overall situation. In order to follow up the variations in the state of PD and heterogenity of symptoms, longer-term measurements performed outside of the clinic could help to optimize and personalize therapies. Several wearable sensors have been used and algorithms have been developed to estimate the severity of symptoms in PD; however, longitudinal recordings, even for shorter duration of few days are rare. Home recordings have the potential benefit of providing a more thorough and objective follow-up about the disease, while providing more information about the possible need to change medications or consider invasive secondary treatments. Objective: The primary objective of this study is to collect a dataset for developing methods for detecting PD-related symptoms that are visible in walking patterns at home. The movement data are collected continuously and remotely at home during the normal lives of patients with Parkinson’s disease, as well as controls. The secondary objective is to use the dataset to study whether the registered medication intakes can be identified from the collected movement data by looking for and analyzing short term changes in the walking patterns. Methods: This observational case-control study protocol measures the activity using three different devices: (1) a smartphone with a built-in accelerometer, gyroscope, and phone orientation sensor, (2) a Movesense® smart sensor to measure movement data from the wrist, and (3) a Forciot® smart insole to measure the temporal and spatial distributions of the forces applied on the feet. The measurements are first collected during the appointment at the clinic through background interviews, a comprehensive Unified Parkinson’s Disease Rating Scale (UPDRS) test, and a 20-step walking test conducted by a trained clinical physiotherapist. After which the subjects wear the smartphone at home for three consecutive days. Wrist and insole sensors are not used in the home recordings. Results: Data collection began in March 2018. The subject recruitment and data collection will continue in spring 2019. The intended sample was 150 subjects. In 2018, we collected a sample of 103 subjects, 66 diagnosed with PD and 37 control subjects. Conclusions: This study aims to produce an extensive movement sensor dataset recorded from PD patients in various phases of the disease, as well as a group of control subjects for effective and impactful comparison studies. The study also aims to develop data analysis methods to monitor PD symptoms and the effects of medication intake during normal life and outside of the clinic. Further applications of these methods may include tools for healthcare professionals to better monitor PD remotely and applying them also to other movement disorders. Clinical Trial: This study is registered under ClinicalTrials.gov (NCT03366558). https://clinicaltrials.gov/ct2/show/NCT03366558?term=k%C3%A4veli&rank=1. Accessed: 2018-08-29. Archived at: http://www.webcitation.org/721n3uIqR

13 November 2018 in JMIR Preprints
Verified
Preprint
Open access
MJMilla Jauhiainen
Milla Jauhiainen
JPJuha Puustinen
Juha Puustinen
SMSaeed Mehrang
Saeed Mehrang
JRJari Ruokolainen
Jari Ruokolainen
AHAnu Holm
Anu Holm
HNHannu Nieminen
Hannu Nieminen
BACKGROUND Clinical characterization of motion in patients with Parkinson disease (PD) is challenging: symptom progression, suitability of medication, and level of independence in the home environment can vary across time and patients. Appointments at the neurological outpatient clinic provide a limited understanding of the overall situation. In order to follow up these variations, longer-term measurements performed outside of the clinic setting could help optimize and personalize therapies. Several wearable sensors have been used to estimate the severity of symptoms in PD; however, longitudinal recordings, even for a short duration of a few days, are rare. Home recordings have the potential benefit of providing a more thorough and objective follow-up of the disease while providing more information about the possible need to change medications or consider invasive treatments. OBJECTIVE The primary objective of this study is to collect a dataset for developing methods to detect PD-related symptoms that are visible in walking patterns at home. The movement data are collected continuously and remotely at home during the normal lives of patients with PD as well as controls. The secondary objective is to use the dataset to study whether the registered medication intakes can be identified from the collected movement data by looking for and analyzing short-term changes in walking patterns. METHODS This paper described the protocol for an observational case-control study that measures activity using three different devices: (1) a smartphone with a built-in accelerometer, gyroscope, and phone orientation sensor, (2) a Movesense smart sensor to measure movement data from the wrist, and (3) a Forciot smart insole to measure the forces applied on the feet. The measurements are first collected during the appointment at the clinic conducted by a trained clinical physiotherapist. Subsequently, the subjects wear the smartphone at home for 3 consecutive days. Wrist and insole sensors are not used in the home recordings. RESULTS Data collection began in March 2018. Subject recruitment and data collection will continue in spring 2019. The intended sample size was 150 subjects. In 2018, we collected a sample of 103 subjects, 66 of whom were diagnosed with PD. CONCLUSIONS This study aims to produce an extensive movement-sensor dataset recorded from patients with PD in various phases of the disease as well as from a group of control subjects for effective and impactful comparison studies. The study also aims to develop data analysis methods to monitor PD symptoms and the effects of medication intake during normal life and outside of the clinic setting. Further applications of these methods may include using them as tools for health care professionals to monitor PD remotely and applying them to other movement disorders. CLINICALTRIAL ClinicalTrials.gov NCT03366558; https://clinicaltrials.gov/ct2/show/NCT03366558 INTERNATIONAL REGISTERED REPOR DERR1-10.2196/12808